Bioinformatics and Current Techniques in Medical Mycology: Combining Laboratory and Clinical Viewpoints

Dear Colleagues,

In terms of diagnosis, treatment, and research, medical mycology is a dynamic discipline that has been confronted with both novel challenges and fascinating future prospects. The goal of this Special Issue is to offer a comprehensive forum covering the full range of fungal infections, from invasive and systemic illnesses to superficial and cutaneous types. Bioinformatics plays a crucial role in fungal epidemiology and retrospective analysis by enabling real-time tracking of outbreaks and resistance surveillance; these methods improve public health responses, increase early identification, and guide antifungal treatment plans. In addition to cutting-edge research on diagnostic advancements, antifungal resistance, treatment approaches, host–pathogen interactions, and public health consequences, the issue will welcome retrospective analyses as well. This issue aims to improve our knowledge of fungal infections and promote interdisciplinary collaborations by connecting clinical findings with laboratory research. The SI idea is to establish a feedback loop in which laboratory findings are quickly and successfully applied in clinical settings, improving patient outcomes and furthering the field of medical mycology, while clinical challenges serve as inspiration for laboratory and computational research.

Case reports, brief communications, thorough reviews, and original research articles are all welcome in this Special Issue. Mycologists, microbiologists, infectious disease specialists, and clinicians are welcome to submit their work, in order to offer a comprehensive perspective on the present and potential future paths of medical mycology.

Aims and Scope:

• Trends in epidemiology—monitoring and bioinformatic tools in fungal infections;
• Diagnostic developments—new methods and difficulties in identifying fungi;
• Mechanisms, clinical consequences, and management approaches of and for antifungal resistance;
• Innovations in therapeutics—drug development and novel therapeutic approaches in antifungal therapy;
• Clinical analyses—both prospective and retrospective research, including series and case reports;
• Pathophysiology and reaction of the host—Molecular discoveries and immunological aspects of fungal infections;
• Multidisciplinary viewpoints—Combining laboratory and translational research with clinical data.

Dr. Dejan Stojković
Dr. Ana Ćirić
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Fungi is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.